scholarly journals SAR Performance of Rectangular Microstrip Antenna for Breast Cancer Hyperthermia Treatment with Different Period of Treatment Procedure

2021 ◽  
Vol 2071 (1) ◽  
pp. 012048
Author(s):  
M M Hassan ◽  
K Lias ◽  
N Buniyamin ◽  
B S S Naimullah ◽  
A T Jobli
Keyword(s):  
Breast Cancer ◽  
Microstrip Antenna ◽  
Specific Absorption Rate ◽  
High Heat ◽  
Cancer Tissue ◽  
Skin Burn ◽  
Hyperthermia Treatment ◽  
Treated Breast ◽  
Rectangular Microstrip Antenna ◽  
Treated Breast Cancer

Abstract Cancer treatment using hyperthermia techniques recently become the interest among researchers in investigating and improving certain deficiencies of the treatment since this treatment has the potential to denaturate cancer into necrotic tissue. Hyperthermia uses high heat from 41°C to 45°C at a certain period of time. It is difficult to control the focus position distance of heat distribution on the treated tissue. Therefore, this paper presents the rectangular microstrip as hyperthermia applicator, which deliver the heat on the targeted treated breast cancer tissue with different period of time in order to obtain sufficient heat or SAR distribution. Sim4LifeLight software simulator is used to design, simulate and generate the specific absorption rate (SAR) distribution on the treated tissue. Three frequencies of 434MHz, 915MHz and 2450MHz are used to be compared. Based on the results, 2450MHz shows better performance than the other two frequencies. However, there is a certain limitation, such as skin burn and unwanted hotspots, that need to be further improved. The cancer is sufficiently heating at different operating frequencies at different periods of procedures.

Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study

2009 ◽  
Vol 49 (1) ◽  
pp. 35-41 ◽  
Author(s):  
Annika Malmström ◽  
Jörgen Hansen ◽  
Lena Malmberg ◽  
Lena Carlsson ◽  
Jan-Henry Svensson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Breast Cancer Patients ◽  
Treated Breast ◽  
Treated Breast Cancer

Endometrial Carcinoma in Tamoxifen-Treated Breast Cancer Patients

1991 ◽  
Vol 3 (4) ◽  
pp. 267-270 ◽  
Author(s):  
G. Spinelli ◽  
N. Bardazzi ◽  
A. Citernesi ◽  
M. Fontanarosa ◽  
P. Curiel
Keyword(s):  
Breast Cancer ◽  
Endometrial Carcinoma ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Treated Breast ◽  
Treated Breast Cancer

Beneficial effects of the redox-active complex Cu[15]pyN5 in doxorubicin-treated breast cancer cells

2012 ◽  
Vol 53 ◽  
pp. S119-S120
Author(s):  
A.S. Fernandes⁎ ◽  
M. Cipriano ◽  
J. Costa ◽  
M.F. Cabral ◽  
J. Miranda ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Active Complex ◽  
Beneficial Effects ◽  
Redox Active ◽  
Treated Breast ◽  
Treated Breast Cancer

Potential Role of β1 Integrin and Collagen Biosynthesis in Estrogen-Dependent Reduction of Apoptosis in Tamoxifen-Treated Breast Cancer Cells

2001 ◽  
Vol 51 (4) ◽  
pp. 248-253 ◽  
Author(s):  
Milena Dabrowska ◽  
Jerzy Palka ◽  
Slawomir Wolczynski ◽  
Miroslawa Pietruczuk ◽  
Joanna Osada
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Potential Role ◽  
Β1 Integrin ◽  
Collagen Biosynthesis ◽  
Treated Breast ◽  
Treated Breast Cancer

scholarly journals MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH

2021 ◽  
Vol 12 (10) ◽  
Author(s):  
Yike Wang ◽  
Lifeng Dong ◽  
Fang Wan ◽  
Fangfang Chen ◽  
Dianlei Liu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Drug Resistance ◽  
Cancer Cells ◽  
Cancer Cell ◽  
Breast Cancer Cells ◽  
Biological Functions ◽  
Qrt Pcr ◽  
Treated Breast ◽  
Cancer Tissues ◽  
Treated Breast Cancer

AbstractThis study explored the role of MTDH in regulating the sensitivity of breast cancer cell lines to gemcitabine (Gem) and the potential miRNAs targeting MTDH. The expression of MTDH in cancer tissues and cells was detected by immunohistochemical staining or qRT-PCR. The target genes for MTDH were predicted by bioinformatics and further confirmed by dual-luciferase reporter assay and qRT-PCR. Cancer cells were transfected with siMTDH, MTDH, miR-9-3p inhibitor, or mimics and treated by Gem, then CCK-8, colony formation assay, tube formation assay, flow cytometry, wound healing assay, and Transwell were performed to explore the effects of MTDH, miR-9-3p, and Gem on cancer cell growth, apoptosis, migration, and invasion. Expressions of VEGF, p53, cleaved caspase-3, MMP-2, MMP-9, E-Cadherin, N-Cadherin, and Vimentin were determined by Western blot. MTDH was high-expressed in cancer tissues and cells, and the cells with high-expressed MTDH were less sensitive to Gem, while silencing MTDH expression significantly promoted the effect of Gem on inducing apoptosis, inhibiting cell migration, invasion, and growth, and on regulating protein expressions of cancer cells. Moreover, miR-9-3p had a targeted binding relationship with MTDH, and overexpressed miR-9-3p greatly promoted the toxic effects of Gem on cancer cells and expressions of apoptosis-related proteins, whereas overexpressed MTDH partially reversed such effects of overexpressed miR-9-3p. The study proved that miR-9-3p regulates biological functions, drug resistance, and the growth of Gem-treated breast cancer cells through targeting MTDH.

Sign in / Sign up

Export Citation Format

Share Document